INTENSIVE CARE FOR COMPLICATIONS FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE AGRANULOCYTOSIS PERIOD IN PATIENTS WITH AUTOIMMUNE DISEASES. ijms [Internet]. 2026 Apr. 29 [cited 2026 Aug. 8];6(4):764-9. Available from: https://www.academicpublishers.org/journals/index.php/ijms/article/view/12907